BR112014008498A2 - composições compreendendo maltotriose e métodos de usar a mesma para inibir danos causados pelos pro-cessos de desidratação - Google Patents

composições compreendendo maltotriose e métodos de usar a mesma para inibir danos causados pelos pro-cessos de desidratação

Info

Publication number
BR112014008498A2
BR112014008498A2 BR112014008498A BR112014008498A BR112014008498A2 BR 112014008498 A2 BR112014008498 A2 BR 112014008498A2 BR 112014008498 A BR112014008498 A BR 112014008498A BR 112014008498 A BR112014008498 A BR 112014008498A BR 112014008498 A2 BR112014008498 A2 BR 112014008498A2
Authority
BR
Brazil
Prior art keywords
maltotriose
compositions
methods
damage caused
dehydration
Prior art date
Application number
BR112014008498A
Other languages
English (en)
Inventor
J Taylor Bradley
m gonzales Juan
Ao Zihua
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46846027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014008498(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of BR112014008498A2 publication Critical patent/BR112014008498A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

resumo patente de invenção: "composições compreendendo maltotriose e métodos de usar a mesma para inibir danos causados pelos processos de desidratação". a presente invenção refere-se a composições compreendendo maltotriose que são descritas aqui. em certas modalidades, as composições compreendem maltotriose de pelo menos um componente cuja função é submeter à deterioração através de um processo de desidratação, tal como um micro-organismo vivo. métodos para inibir dano causado pela desidratação são também descritos aqui. em modalidades particulares, o método inclui preparar uma composição compreendendo maltotriose e pelo menos um componente, cuja função é submeter à deterioração por um processo de desidratação e remover a água da composição por um ou mais processos de desidratação.
BR112014008498A 2011-10-11 2012-09-06 composições compreendendo maltotriose e métodos de usar a mesma para inibir danos causados pelos pro-cessos de desidratação BR112014008498A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/270,607 US20130089638A1 (en) 2011-10-11 2011-10-11 Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
PCT/US2012/053855 WO2013055463A1 (en) 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Publications (1)

Publication Number Publication Date
BR112014008498A2 true BR112014008498A2 (pt) 2017-04-11

Family

ID=46846027

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014008498A BR112014008498A2 (pt) 2011-10-11 2012-09-06 composições compreendendo maltotriose e métodos de usar a mesma para inibir danos causados pelos pro-cessos de desidratação

Country Status (15)

Country Link
US (1) US20130089638A1 (pt)
EP (1) EP2765872A1 (pt)
CN (2) CN103929979A (pt)
AR (1) AR088035A1 (pt)
BR (1) BR112014008498A2 (pt)
CA (1) CA2852109A1 (pt)
CO (1) CO6940418A2 (pt)
EC (1) ECSP14000460A (pt)
HK (2) HK1199797A1 (pt)
MX (1) MX2014004060A (pt)
PE (1) PE20142080A1 (pt)
RU (1) RU2014110708A (pt)
SG (1) SG11201400696XA (pt)
TW (2) TW201822640A (pt)
WO (1) WO2013055463A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3369805B1 (en) 2015-10-30 2020-08-26 Kabushiki Kaisha Yakult Honsha Method for producing dried microbial cells
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792183A (en) * 1971-08-10 1974-02-12 Nabisco Inc Cereal coating composition and process
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
US4814267A (en) * 1984-09-18 1989-03-21 Michigan Biotechnology Institute Method for preparing high conversion syrups and other sweeteners
ATE100855T1 (de) * 1988-11-10 1994-02-15 Takeda Chemical Industries Ltd Saure urease-zubereitungen fuer alkoholische getraenke.
US5145697A (en) * 1989-04-26 1992-09-08 Mpy Foods, Inc. Instant yogurt composition and process
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
EP1787532A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixtures and uses thereof
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
AU682162B2 (en) 1993-11-17 1997-09-25 Niro Holding A/S A process and a spray drying apparatus for producing an agglomerated powder
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ATE298363T1 (de) * 1996-07-09 2005-07-15 Nestle Sa Verfahren zur sprühtrocknung
US6223455B1 (en) 1999-05-03 2001-05-01 Acusphere, Inc. Spray drying apparatus and methods of use
US6463675B1 (en) 1999-09-29 2002-10-15 Niro A/S Process and a plant for spray drying
US6322994B1 (en) * 1999-11-04 2001-11-27 Genetix Limited Method of freeze-drying organisms
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
FR2829147B1 (fr) * 2001-08-30 2003-12-12 Agronomique Inst Nat Rech Procede de preparation d'une composition lyophilisee contenant des bacteries lactiques a viabilite et activite bacteriennes ameliorees lors d'un stockage a temperature ambiante et composition obtenue
US6838097B1 (en) * 2001-12-14 2005-01-04 Stephen Tsengas Pet food product
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
WO2006029467A1 (en) * 2004-09-16 2006-03-23 Btf Pty Ltd Rapid freeze drying process
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
MX2007007181A (es) * 2004-12-21 2007-08-14 Firmenich & Cie Acidos grasos poliinsaturados encapsulados.
KR101229855B1 (ko) * 2005-03-31 2013-02-05 미쓰비시 가가꾸 가부시키가이샤 열화 방지제
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
WO2007058027A1 (ja) * 2005-11-18 2007-05-24 Idemitsu Kosan Co., Ltd. バチルス・チューリンゲンシスを含む有害菌の防除剤
JP4889317B2 (ja) * 2006-02-17 2012-03-07 オリエンタル酵母工業株式会社 マルトトリオース高含有組成物及びその製造方法
EP1903291A1 (en) 2006-09-19 2008-03-26 Ima-Telstar S.L. Method and system for controlling a freeze drying process
MX2010006887A (es) * 2007-12-20 2010-10-15 Abbott Lab Polvo nutricional estable.
MX2010009351A (es) * 2008-02-25 2011-03-04 Novavax Inc Particulas similares a virus cristalizadas con azucar.
CN101313715A (zh) * 2008-07-09 2008-12-03 内蒙古蒙牛乳业（集团）股份有限公司 一种添加维生素适用于12到36个月的婴儿液态乳
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
PT2603100T (pt) * 2010-08-13 2018-07-16 Advanced Bionutrition Corp Composição de estabilização para armazenamento a seco de materiais biológicos

Also Published As

Publication number Publication date
CA2852109A1 (en) 2013-04-18
TW201822640A (zh) 2018-07-01
SG11201400696XA (en) 2014-08-28
EP2765872A1 (en) 2014-08-20
HK1250315A1 (zh) 2018-12-14
TW201325460A (zh) 2013-07-01
HK1199797A1 (en) 2015-07-24
CN103929979A (zh) 2014-07-16
CO6940418A2 (es) 2014-05-09
RU2014110708A (ru) 2015-11-20
MX2014004060A (es) 2014-07-09
AR088035A1 (es) 2014-05-07
PE20142080A1 (es) 2014-12-24
WO2013055463A1 (en) 2013-04-18
ECSP14000460A (es) 2015-06-30
US20130089638A1 (en) 2013-04-11
CN107647394A (zh) 2018-02-02

Similar Documents

Publication Publication Date Title
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BR112015018474A2 (pt) borracha natural modificada, processo para produzir a mesma, composição de borracha para pneu e pneumático
CO6382129A2 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o provencion de diabetes
CO6361922A2 (es) Inhibidores del virus de la hepatitis c
BR112014024287A2 (pt) composições e métodos para a prevenção e tratamento do derrame vascular induzido por mastócitos
WO2010029302A3 (en) Compounds for treating viral infections
BR112016006527A2 (pt) composto, composição, utilização de um composto e método para o controle da vegetação
BR112014015910A8 (pt) composição
BR112014029329A2 (pt) aminoamidas semelhantes ao dendrímero possuindo atividade bloqueadora de canal de sódio para o tratamento de olho seco e outras doenças mucosais
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
BR112012028711A2 (pt) métodos para a fabricação de uma emulsão de óleo em água, para a preparação de um kit de vacina e para redestilação de uma composição compreendendo 99% de esqualeno ou mais, assim como emulsão de óleo em água e kit
BR112013000776A2 (pt) método e formulação para tratamento de deficiência de ácido siálico
BR112013031307A2 (pt) métodos para tratamento de material lignocelulósico
BR112013020042A2 (pt) inibidores de vírus da hepatite c
BR112015008037A2 (pt) compostos, processo para a preparação de um composto, composição farmacêutica, utilização do composto, método para o tratamento do câncer e invenção
BR112013032049A2 (pt) inibidores do vírus da hepatite c
WO2014053401A3 (en) Method of improving plant health
BR112015001655A2 (pt) método para purificar pelo menos uma saponina em uma solução, componente de produto de saponina qs-21 purificada, e, composição imunogênica
ES2721623T3 (es) Procedimiento novedoso para la preparación de ceftarolina fosamil
BR112015014583B1 (pt) compostos, processo para a preparação de compostos, compostos intermediários, composição, usos de um composto de fórmula i e método para combater fungos nocivos
BR112014029378A2 (pt) composição para recuperação de óleo e método para recuperar óleo
BR112017028088A2 (pt) ?composição de barra de limpeza, utilização da composição, processo para preparar a composição e método de limpeza de uma superfície?
BR112017028362A2 (pt) composições aditivas para a eliminação de sulfeto de hidrogênio, e o meio compreendendo as mesmas
EA201591180A1 (ru) Составы ингибитора lfa-1

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A23L 33/135 (2016.01), A23L